Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.84 USD | +0.09% | -2.41% | +266.54% |
06-24 | Janux Therapeutics, Inc.(NasdaqGM:JANX) added to S&P Biotechnology Select Industry Index | CI |
06-06 | Janux Therapeutics Insider Sold Shares Worth $45,043,975, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+266.54% | 2.06B | |
+20.46% | 46.93B | |
+37.97% | 39.08B | |
-8.10% | 38.48B | |
+29.54% | 31.01B | |
-12.26% | 26.14B | |
+11.35% | 25.88B | |
+34.96% | 12.53B | |
-6.84% | 11.36B | |
-12.58% | 10.65B |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- Scotiabank Starts Janux Therapeutics With Sector Perform Rating